Is central memory T-lymphocyte therapy available for hepatocellular carcinoma in China?

Yes. The therapy is available through Le City licensed use in Hainan at Hainan Haikong Le City Hospital, subject to medical evaluation and applicable requirements.

How much does hepatocellular carcinoma immunotherapy cost in China?

The estimated cost is ¥120,000 (approximately US$17,700) per session. Patients should confirm the final price and what it includes directly with the hospital.

Who may qualify for central memory T-lymphocyte therapy?

Hepatocellular carcinoma is the identified indication, but detailed individual eligibility criteria are not specified. Final eligibility requires assessment by the treating medical team.

Is central memory T-lymphocyte therapy approved throughout China?

No nationwide approval should be inferred from Le City licensed use. The treatment has a specific access pathway in Hainan, while its efficacy and safety remain under evaluation.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Central Memory T-Lymphocyte Therapy for Hepatocellular Carcinoma in China: 2026 International Patient Guide — Hepatocellular Carcinoma Immunotherapy China

ChinaCureLink

Fri Sep 04 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page